Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant.
about
Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.Influenza infection in infants aged <6 months during the H1N1-09 pandemic: a hospital-based case series.Oseltamivir pharmacokinetics and clinical experience in neonates and infants during an outbreak of H1N1 influenza A virus infection in a neonatal intensive care unitInhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivirPopulation pharmacokinetics of oseltamivir: pediatrics through geriatrics.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.Rates and effectiveness of antiviral use among hospitalized influenza patients.Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development.Pharmacokinetics of oseltamivir in infants under the age of 1 year.Oseltamivir dosing in premature infants.ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.Viral Respiratory Infections in the Neonatal Intensive Care Unit-A Review
P2860
Q30373969-D06A0EDE-1FF8-42F6-8F3A-844152C770C3Q30432134-F0FAAEDB-C017-4E35-B2B3-8A30DA04DD30Q36086446-C583D031-2B0A-4A0D-B7E2-173C85663DA3Q36783997-D63D99C0-87AA-4848-91AD-59B46214EAD9Q37036527-783E3242-E658-42E8-9B68-EEC463EFFDFFQ38084212-2C1E4599-C396-40BD-AD9B-DF51A57A3D76Q38476530-8093D767-4F0A-4DF9-9FF3-666CBB42D458Q38797102-D60367B2-3EFF-4D72-972E-2CAE760A256EQ39421486-5F5D0EDF-C4EB-4765-901C-132BA9A218B9Q41890159-5164B7E3-4B84-4393-8218-F95A96FD9C5FQ48910582-A2990C59-0DAD-4B8A-A70E-4BB19382BEBCQ58587564-59F3EFA0-92D4-4F81-8A85-45AA4EFF8B87
P2860
Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacologic considerations f ...... the neonate and young infant.
@ast
Pharmacologic considerations f ...... the neonate and young infant.
@en
type
label
Pharmacologic considerations f ...... the neonate and young infant.
@ast
Pharmacologic considerations f ...... the neonate and young infant.
@en
prefLabel
Pharmacologic considerations f ...... the neonate and young infant.
@ast
Pharmacologic considerations f ...... the neonate and young infant.
@en
P2093
P1433
P1476
Pharmacologic considerations f ...... the neonate and young infant.
@en
P2093
Gregory L Kearns
Jason G Newland
Susan M Abdel-Rahman
P356
10.2165/11536950-000000000-00000
P577
2011-02-01T00:00:00Z
P6179
1008120872